MedVellum
MedVellum
Back to Library
Emergency Medicine
Neurology
Intensive Care
EMERGENCY

Status Epilepticus

High EvidenceUpdated: 2024-12-21

On This Page

Red Flags

  • Seizure lasting over 5 minutes
  • Recurrent seizures without recovery
  • Hypoxia during seizure
  • Hyperthermia
  • Not responding to first-line benzodiazepines
  • New-onset status in non-epileptic patient
Overview

Status Epilepticus

Topic Overview

Summary

Status epilepticus (SE) is defined as continuous seizure activity lasting over 5 minutes or recurrent seizures without regaining consciousness between episodes. It is a medical emergency with mortality of 10-20% and requires rapid, stepwise treatment. First-line is benzodiazepines (lorazepam IV or buccal midazolam); escalate through second-line (levetiracetam/phenytoin/valproate) to third-line (anaesthetic agents) if seizures persist.

Key Facts

  • Definition: Seizure over 5 minutes OR ≥2 seizures without recovery
  • Mortality: 10-20%; higher in refractory SE and elderly
  • First-line: Lorazepam 4mg IV or midazolam 10mg IM/buccal
  • Second-line: Levetiracetam, phenytoin, or valproate IV
  • Third-line: RSI + propofol/thiopentone/midazolam infusion (ICU)
  • Causes: Medication non-compliance, alcohol withdrawal, stroke, metabolic, infection, tumour

Clinical Pearls

"Time is brain" — neuronal damage increases with seizure duration; aim for seizure termination within 30 minutes

If no IV access: buccal/IM midazolam or rectal diazepam are effective first-line alternatives

Always consider non-convulsive status epilepticus in prolonged altered consciousness

Why This Matters Clinically

Status epilepticus causes progressive neuronal injury, systemic complications (aspiration, rhabdomyolysis, hyperthermia), and death. Rapid escalation through treatment stages is essential. Every clinician must know the stepwise protocol.


Visual Summary

Visual assets to be added:

  • Status epilepticus treatment algorithm (timed protocol)
  • Benzodiazepine dosing chart
  • ECG/EEG during status
  • Causes of status epilepticus infographic

Epidemiology

Incidence

  • Overall: 10-40 per 100,000/year
  • Mortality: 10-20% (higher in refractory SE, elderly, anoxic)
  • Morbidity: 10-20% develop new neurological deficits

Demographics

  • Bimodal age distribution: Children under 1 year and elderly
  • More common in males

Aetiology

CauseNotes
Known epilepsyAED non-compliance (most common in known epileptics), breakthrough
Alcohol withdrawalCommon in acute hospitals
Stroke/haemorrhageEspecially acute phase
CNS infectionMeningitis, encephalitis
MetabolicHypoglycaemia, hyponatraemia, hypocalcaemia, uraemia
Drug toxicityTheophylline, tramadol, antipsychotics
TumourNew or known
Head injuryAcute or late
Anoxic brain injuryPost-cardiac arrest

Pathophysiology

Progressive Seizure Pathophysiology

Phase 1 (0-30 min):

  • GABA-A receptor internalisation → reduced inhibitory control
  • Glutamate release → excitotoxicity
  • Initial compensation (catecholamine surge)

Phase 2 (30-60 min):

  • NMDA receptor activation → calcium influx → neuronal injury
  • Metabolic demand exceeds supply
  • Lactate accumulation, acidosis

Phase 3 (over 60 min):

  • Failure of homeostatic mechanisms
  • Hyperthermia, rhabdomyolysis, multi-organ failure
  • Irreversible neuronal death

Why Benzodiazepines Become Less Effective

  • GABA-A receptor internalisation during prolonged seizures
  • Explains need for early treatment and escalation

Clinical Presentation

Convulsive Status Epilepticus (Most Common)

Non-Convulsive Status Epilepticus (NCSE)

Focal Motor Status

Red Flags

FeatureSignificance
Not responding to 1st-line benzodiazepinesProceed to 2nd-line immediately
HyperthermiaSuggests prolonged seizure; poor prognosis
New-onset in non-epilepticSearch for underlying cause (stroke, infection, metabolic)
Post-arrestAnoxic injury — prognosis guarded

Continuous tonic-clonic movements
Common presentation.
Unresponsive GCS
Common presentation.
May evolve from discrete tonic-clonic movements to subtle myoclonus
Common presentation.
Clinical Examination

Initial Assessment

  • Airway: Patent? Secretions? Recovery position
  • Breathing: SpO₂, give O₂
  • Circulation: HR, BP, IV access
  • Disability: Nature of seizure activity, pupil response
  • Exposure: Temperature, signs of trauma

During Seizure

  • Protect from injury
  • Do NOT restrain
  • Do NOT insert anything in mouth
  • Time the seizure

Post-Ictal

  • GCS
  • Focal signs (Todd's paresis suggests focal onset)
  • Fever (infection as cause)
  • Signs of trauma (tongue bite, injuries)

Investigations

Immediate (Bedside)

TestPurpose
Blood glucoseHypoglycaemia — treat immediately
SpO₂Hypoxia
TemperatureHyperthermia
ECGArrhythmias, QTc (drug-induced)

Laboratory

TestPurpose
U&ESodium, potassium, calcium, renal function
GlucoseConfirm fingerprick
Calcium, magnesiumMetabolic causes
AED levelsCompliance, toxicity
FBCInfection
ABG/VBGAcidosis, lactate
CKRhabdomyolysis
Toxicology screenIf cause unclear

Imaging

  • CT Head: If new-onset, focal onset, trauma, or cause unclear
  • Urgent if suspected structural cause

EEG

  • If NCSE suspected
  • Continuous EEG monitoring in ICU for refractory SE

Classification & Staging

By Timing

StageDurationTerm
Early SE5-30 minImpending SE
Established SE30-60 minEstablished SE
Refractory SEOver 60 min or persists despite 2 AEDsRefractory SE
Super-refractory SEOver 24h despite anaesthesia OR recurs on weaningSuper-refractory SE

By Type

  • Convulsive (generalised tonic-clonic)
  • Non-convulsive (absence, focal aware/impaired awareness)
  • Focal motor (epilepsia partialis continua)

Management

Time-Based Protocol (UK Modified)

0-5 MINUTES: STABILISE

  • Airway, O₂, recovery position
  • Check glucose — treat hypoglycaemia
  • IV access

5-10 MINUTES: FIRST-LINE (BENZODIAZEPINES)

DrugDoseRoute
Lorazepam4mg (0.1mg/kg)IV — repeat once in 5-10 min if needed
Midazolam10mgIM or buccal (if no IV access)
Diazepam10mgIV or rectal

10-20 MINUTES: SECOND-LINE (IF SEIZURES PERSIST) Choose ONE:

DrugDoseNotes
Levetiracetam60mg/kg (max 4.5g) IV over 10 minFewer interactions; safe in liver disease
Phenytoin20mg/kg IV (max 50mg/min)ECG monitoring; avoid if hypotension
Valproate40mg/kg IV (max 3g) over 10 minAvoid in pregnancy, liver disease

20-40 MINUTES: THIRD-LINE (GENERAL ANAESTHESIA)

  • Rapid sequence induction (RSI)
  • Propofol infusion (2-5 mg/kg/hr) OR
  • Midazolam infusion (0.05-0.4 mg/kg/hr) OR
  • Thiopentone (3-5 mg/kg bolus, infusion)
  • ICU admission, continuous EEG monitoring
  • Burst suppression target

Treat Underlying Cause

  • Glucose if hypoglycaemia
  • Thiamine if alcohol-related/malnourished
  • Antibiotics if infection
  • Correct electrolyte abnormalities

Pyridoxine

  • Consider IV pyridoxine (100-300mg) in:
    • Isoniazid overdose
    • Refractory SE of unknown cause

Complications

From Prolonged Seizure

  • Neuronal injury (hippocampal sclerosis)
  • New epilepsy
  • Cognitive impairment
  • Aspiration pneumonia
  • Rhabdomyolysis → AKI
  • Hyperthermia
  • Fractures, dislocations (vertebral, shoulder)
  • Death

From Treatment

  • Respiratory depression (benzodiazepines)
  • Hypotension (propofol, phenytoin)
  • Purple glove syndrome (phenytoin extravasation)
  • Propofol infusion syndrome (rare, prolonged use)

Prognosis & Outcomes

Mortality

  • Overall: 10-20%
  • Anoxic SE: Very high mortality and poor neurological outcomes
  • Drug-induced/alcohol SE: Generally better outcomes

Prognostic Factors

FactorImpact
DurationLonger = worse
CauseAnoxic and CNS infection = worst
AgeElderly = higher mortality
Refractory SEHigher mortality
ComorbiditiesHigher mortality

Evidence & Guidelines

Key Guidelines

  1. NICE CG137: Epilepsies — updated 2022
  2. Advanced Life Support (Resus Council UK) — Seizure Algorithm
  3. American Epilepsy Society Guidelines for Status Epilepticus

Key Trials

  • RAMPART Trial: IM midazolam as effective as IV lorazepam for pre-hospital SE
  • ESETT Trial: Levetiracetam, fosphenytoin, and valproate equally effective as second-line

Patient & Family Information

What is Status Epilepticus?

Status epilepticus is a seizure that lasts too long (more than 5 minutes) or seizures that happen one after another without the person waking up. It is a medical emergency.

What to Do If Someone Has a Prolonged Seizure

  • Call 999 immediately
  • Keep them safe from injury
  • Do NOT put anything in their mouth
  • Time the seizure
  • If prescribed emergency medication (buccal midazolam or rectal diazepam), give it

After Treatment

  • Investigation to find the cause
  • Adjustment of regular epilepsy medication if needed
  • Follow-up with neurology

Resources

  • Epilepsy Action
  • Epilepsy Society
  • NHS Epilepsy

References

Primary Guidelines

  1. NICE. Epilepsies: Diagnosis and Management (CG137/NG217). 2022. nice.org.uk
  2. Resuscitation Council UK. Adult Advanced Life Support: Seizure Algorithm. resus.org.uk

Key Trials

  1. Silbergleit R, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus (RAMPART). N Engl J Med. 2012;366(7):591-600. PMID: 22335736
  2. Kapur J, et al. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus (ESETT). N Engl J Med. 2019;381(22):2103-2113. PMID: 31774955

Last updated: 2024-12-21

At a Glance

EvidenceHigh
Last Updated2024-12-21
Emergency Protocol

Red Flags

  • Seizure lasting over 5 minutes
  • Recurrent seizures without recovery
  • Hypoxia during seizure
  • Hyperthermia
  • Not responding to first-line benzodiazepines
  • New-onset status in non-epileptic patient

Clinical Pearls

  • "Time is brain" — neuronal damage increases with seizure duration; aim for seizure termination within 30 minutes
  • If no IV access: buccal/IM midazolam or rectal diazepam are effective first-line alternatives
  • Always consider non-convulsive status epilepticus in prolonged altered consciousness
  • **Visual assets to be added:**
  • - Status epilepticus treatment algorithm (timed protocol)

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines